In response to the recent @NYTimes editorial on cannabis and as a committee member on the @theNASEM #cannabis and #cannabinoids report we did NOT conclude that cannabis causes schizophrenia.

What Advocates of Legalizing Pot Don’t Want You to Know nyti.ms/2Rw2ngF

We found 1) an #association between cannabis use and schizophrenia and 2) an #association between cannabis use and IMPROVED cognitive outcomes in individuals with psychotic disorders (not mentioned in the editorial).

Since the report, we now know that genetic risk for schizophrenia predicts cannabis use, shedding some light on the potential direction of the association between cannabis use and schizophrenia.
ncbi.nlm.nih.gov/pubmed/30150663

We also now know that under placebo-controlled conditions, #cannabidiol (#CBD) improves outcomes in patients with schizophrenia when given as an adjunct med, showing that cannabinoids (not necessarily cannabis) improve symptoms.
ncbi.nlm.nih.gov/pubmed/29241357

Download the @theNASEM report to learn more about the over 100 #associations between #cannabis, #cannabinoids, and #health outcomes.

nationalacademies.org/hmd/Reports/20…